Naltrexone: Clinically Proven Anti-Alcohol Medication
| Product dosage: 50mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $7.15 | $214.43 (0%) | 🛒 Add to cart |
| 60 | $6.76 | $428.86 $405.82 (5%) | 🛒 Add to cart |
| 90 | $6.62
Best per pill | $643.29 $596.20 (7%) | 🛒 Add to cart |
Synonyms | |||
Naltrexone is a prescription medication approved by the FDA for the treatment of alcohol use disorder (AUD). As an opioid receptor antagonist, it works by blocking the euphoric effects and feelings of intoxication associated with alcohol consumption. This pharmacological action supports reduced drinking behaviors, aids in maintaining abstinence, and is a cornerstone of medication-assisted treatment (MAT) when combined with comprehensive counseling and behavioral therapies. It represents a critical tool in the modern medical management of alcohol dependence.
Features
- Active ingredient: Naltrexone Hydrochloride
- Available formulations: 50 mg oral tablets and extended-release intramuscular injections (380 mg/vial)
- Mechanism of action: Opioid receptor antagonist
- Prescription status: Schedule-controlled substance requiring medical supervision
- Standard course: Typically prescribed as part of a long-term treatment plan
Benefits
- Reduces alcohol craving by modulating the brain’s reward pathways
- Decreases the frequency of heavy drinking episodes
- Supports long-term abstinence when used as part of a comprehensive treatment plan
- Helps break the cycle of alcohol dependence by diminishing its reinforcing effects
- Available in both daily oral and monthly injectable forms for flexible adherence
- Evidence-based efficacy demonstrated in multiple randomized controlled trials
Common use
Naltrexone is indicated for the management of alcohol dependence in adults who have undergone detoxification and are committed to maintaining a state of abstinence. It is used as one component of a comprehensive treatment program that includes psychosocial support, counseling, and monitoring. It is suitable for patients seeking to reduce alcohol consumption or achieve complete abstinence, and is often prescribed following an initial evaluation by an addiction specialist or psychiatrist.
Dosage and direction
The recommended dosage for naltrexone in the treatment of alcohol dependence is 50 mg once daily, administered orally. Alternatively, a monthly intramuscular injection of 380 mg may be administered by a healthcare professional. Treatment should be initiated only after the patient has remained opioid-free for at least 7–10 days to avoid precipitating withdrawal. Adherence to the prescribed regimen is critical for therapeutic efficacy. Dosage adjustments are not typically required for hepatic or renal impairment, but caution is advised.
Precautions
Patients should be advised that naltrexone may cause hepatocellular injury when taken in excess; liver function tests are recommended prior to and during therapy. Use with caution in patients with moderate to severe renal impairment. Naltrexone may precipitate acute withdrawal in patients dependent on opioids. It is important to carry medical identification indicating naltrexone use in case of emergency. Avoid abrupt discontinuation without medical supervision.
Contraindications
Naltrexone is contraindicated in patients receiving opioid analgesics, those with current physiologic opioid dependence, or those in acute opioid withdrawal. It should not be used in individuals with acute hepatitis or liver failure. Hypersensitivity to naltrexone or any component of the formulation is also a contraindication. Concomitant use with opioid-containing medications (e.g., cough suppressants, antidiarrheals) is prohibited.
Possible side effects
Common side effects include nausea (∼10%), headache (∼7%), dizziness (∼4%), fatigue, insomnia, and anxiety. Less frequently, patients may experience vomiting, decreased appetite, joint pain, or muscle cramps. Injection-site reactions (e.g., pain, induration, swelling) are common with the extended-release formulation. Serious but rare adverse effects include hepatotoxicity, depression, suicidality, and eosinophilic pneumonia.
Drug interaction
Naltrexone may block the effects of opioid-containing medications, including analgesics, antitussives, and antidiarrheals. Concurrent use with hepatotoxic drugs (e.g., acetaminophen) may increase the risk of liver injury. Caution is advised when used with other centrally acting agents. No clinically significant interactions with alcohol itself are noted, though the goal of therapy is to avoid alcohol consumption.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next dose. In that case, the missed dose should be skipped and the regular dosing schedule resumed. Doubling the dose is not recommended. For the injectable form, contact the healthcare provider to reschedule the missed injection.
Overdose
There is no specific antidote for naltrexone overdose. Management is supportive and symptomatic. In cases of suspected overdose, seek immediate medical attention. Hemodialysis is not expected to enhance elimination. Accidental ingestion of opioids while on naltrexone may require higher-than-usual doses of opioids to achieve analgesia, with careful monitoring for respiratory depression.
Storage
Store at room temperature (20–25°C or 68–77°F). Oral tablets should be kept in their original container, away from moisture and light. The injectable suspension must be refrigerated (2–8°C or 36–46°F) and protected from light. Keep out of reach of children and pets. Do not use beyond the expiration date.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read herein.
Reviews
Clinical studies and meta-analyses consistently demonstrate naltrexone’s efficacy in reducing alcohol consumption and supporting abstinence. Patient reports often highlight reduced cravings and improved quality of life when used as directed under medical supervision. Individual results may vary, and success is highly dependent on adherence to a full treatment program including behavioral support.